Suppr超能文献

Spironolactone and risk of upper gastrointestinal events: causality remains unconvincing.

作者信息

Jones Gruffydd P

出版信息

BMJ. 2006 Sep 2;333(7566):501. doi: 10.1136/bmj.333.7566.501-a.

Abstract
摘要

相似文献

1
Spironolactone and risk of upper gastrointestinal events: causality remains unconvincing.
BMJ. 2006 Sep 2;333(7566):501. doi: 10.1136/bmj.333.7566.501-a.
2
Upper gastrointestinal bleeding and spironolactone.
Prescrire Int. 2011 Apr;20(115):98-9.
3
Spironolactone and risk of upper gastrointestinal events: association is unproved.
BMJ. 2006 Sep 2;333(7566):501. doi: 10.1136/bmj.333.7566.501.
4
Spironolactone and risk of upper gastrointestinal events: spironolactone may not be guilty.
BMJ. 2006 Sep 2;333(7566):500; author reply 500-1. doi: 10.1136/bmj.333.7566.500-c.
6
Spironolactone-induced gynecomastia.
CMAJ. 2007 Feb 27;176(5):620. doi: 10.1503/cmaj.061286.
7
New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
Expert Opin Drug Saf. 2005 Jul;4(4):677-88. doi: 10.1517/14740338.4.4.677.
8
Treatment of heart failure with spironolactone--trial and tribulations.
N Engl J Med. 2004 Aug 5;351(6):526-8. doi: 10.1056/NEJMp048144.
9
Tolerability of spironolactone in patients with chronic heart failure -- a cautionary message.
Br J Clin Pharmacol. 2004 Nov;58(5):554-7. doi: 10.1111/j.1365-2125.2004.02187.x.
10
Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
BMJ. 2004 Aug 21;329(7463):420. doi: 10.1136/bmj.329.7463.420-e.

本文引用的文献

1
Spironolactone and risk of upper gastrointestinal events: population based case-control study.
BMJ. 2006 Aug 12;333(7563):330. doi: 10.1136/bmj.38883.479549.2F. Epub 2006 Jul 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验